UNSPSC 51392804: Zindotrine

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C11H15N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VQM3328PO0, chemically known as 1,2,4-triazolo(4,3-b)pyridazine, 8-methyl-6-(1-piperidinyl)- but generally known as zindotrine, which bears US NIH Compound Identifier 41856. European Medicines Agency schedules Zindotrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00162MIG.

UNSPSC 51392804 Zindotrine, a Commodity code, covers pharmaceutical products and related health intervention systems that state and local governments procure to support community health and public safety initiatives. Recent activity shows state and local buyers sourcing naloxone, drug deactivation systems, and direct-to-manufacturer prescription programs — reflecting a shift toward harm-reduction and cost-management strategies in public health procurement. The issuing bodies span county health departments and state health agencies; Seminole County, Florida and the Texas Health and Human Services Commission represent the recent solicitation activity in this dataset.

Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023 (note: the source contains an inconsistent date). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured employee health plans and state agencies, signaling early-stage market research before formal procurement. Geographic spread is limited in the recent-opportunities block to Florida and Texas; no other states appear in the source material. The Seminole County procurement requires E-Verify compliance, drug-free workplace certification, and workers' compensation and commercial general liability insurance, with a three-month probationary period and potential FEMA funding subject to federal environmental compliance. Neither solicitation specifies set-aside designations for disadvantaged enterprises.